Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
Preoperative Brain Mapping Predicts Language Outcomes After Eloquent Tumor Resection, Matthew T Muir, Kyle Noll, Sarah Prinsloo, et al.
Risk Factors and Clinical Significance of Urologic Injury in Cesarean Hysterectomy for Placenta Accreta Spectrum, J Connor Mulhall, Kayla E Ireland, John J Byrne, et al.
SARS-CoV-2 RNA-Binding Protein Suppresses Extracellular miRNA Release, Hyejin Mun, Chang Hoon Shin, Qingxuan Fei, et al.
Non-canonical Splice Variants in Thoracic Aortic Dissection Cases and Marfan Syndrome With Negative Genetic Testing, David R Murdock, Dong-Chuan Guo, John S DePaolo, et al.
Early Diagnosis of Vascular Ehlers-Danlos Syndrome Through AI-Powered Facial Analysis: Results From the Montalcino Aortic Consortium, David R Murdock, Adarsh Suresh, Ernesto Calderon Martinez, et al.
Trametinib Decreased Intracerebral Hemorrhages and Endothelial-to-Mesenchymal Transition in KRAS, Ohnmar Myint, Bridger Freeman, Jae Yeong Jeong, et al.
A Large-Scale Genome-Wide Study of Gene-Sleep Duration Interactions for Blood Pressure in 811,405 Individuals From Diverse Populations, Pavithra Nagarajan, Thomas W Winkler, Amy R Bentley, et al.
Wnt-Directed CXCL12-Expressing Apical Papilla Progenitor Cells Drive Tooth Root Formation, Mizuki Nagata, Gaurav T Gadhvi, Taishi Komori, et al.
A Hedgehog-Foxf Axis Coordinates Dental Follicle-Derived Alveolar Bone Formation, Mizuki Nagata, Gaurav T Gadhvi, Taishi Komori, et al.
Diet and Survival After a Diagnosis of Ovarian Cancer: A Pooled Analysis From the Ovarian Cancer Association Consortium, Christina M Nagle, Torukiri I Ibiebele, Renhua Na, et al.
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study, Aung Naing, Amit Mahipal, Milind Javle, et al.
TIGIT Inhibitor M6223 As Monotherapy or in Combination With Bintrafusp Alfa in Patients With Advanced Solid Tumors: A First-in-Human, Phase 1, Dose-Escalation Trial, Aung Naing, Meredith McKean, Anthony Tolcher, et al.
Multiomic Random Forest Toxicity Modeling of Radiation Esophagitis, Saurabh S Nair, Ramon M Salazar, Ting Xu, et al.
Generation of Human Induced Pluripotent Stem Cell Line From a Familial Alzheimer’s Disease Patient Carrying Missense Mutations in PSEN1 and MAPT Genes, Ashaq H Najar, Sofia E Sepulveda, Camila Gherardelli, et al.
Bone Marrow Endosteum in Homeostasis and Metastasis, Yuta Nakai, Wanida Ono, and Noriaki Ono
Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial, Mirella Nardo, Camila Braganca Xavier, Bettzy Stephen, et al.
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial, Mirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
Natural History Models for Lung Cancer: A Scoping Review, Renu Sara Nargund, Sayaka Ishizawa, Maryam Eghbalizarch, et al.
Childhood Trauma and Inflammatory Biomarker Effects on Cortical Thinning in Schizophrenia Spectrum Disorders, Samantha Narvaez, Yizhou Ma, Joshua Chiappelli, et al.
First-Line PD-1 +/- CTLA-4 Blockade in Patients With Deficient Mismatch Repair and/or Microsatellite Instability-High Metastatic Colorectal Cancer, Vincenzo Nasca, Gabriele Tinè, Julien Taieb, et al.
Sex and Outcomes of Patients With Microsatellite Instability-High and Braf V600E Mutated Metastatic Colorectal Cancer Receiving Immune Checkpoint Inhibitors, Vincenzo Nasca, Joseph Zhao, Javier Ros, et al.
Retrospective Review of Metastatic Hormone Receptor-Positive Inflammatory Breast Cancer Patients Reveals Poor Responses to Cyclin Dependent Kinase 4/6 Inhibition, Azadeh Nasrazadani, Rebecca S Tidwell, Megumi Kai, et al.
Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC, Amin H Nassar, Ritujith Jayakrishnan, Jamie Feng, et al.
Author Correction: Oncolytic Dnx-2401 Virotherapy Plus Pembrolizumab in Recurrent Glioblastoma: A Phase 1/2 Trial, Farshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma, Loretta J Nastoupil, Clark R Andersen, Amy Ayers, et al.